News | Checkpoint inhibitors and COVID-19 mortality; HCC rates slow in cities, continue to climb in rural areas Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest: HCC rates slow in cities, continue to climb in rural areas:…
Tag